[Issues and implementation of postoperative radiotherapy after flap reconstructive surgery in head and neck cancers].

Enjeux et mise en œuvre de radiothérapie postopératoire après chirurgie reconstructrice avec lambeau dans les cancers de la tête et du cou.
Cancer de la tête et du cou Chirurgie reconstructive Flap, Radiotherapy Head and neck cancer Lambeau Radiothérapie Recommandations Recommendations Reconstructive surgery Target volume Volumes cibles

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
28 Mar 2024
Historique:
received: 05 11 2023
revised: 23 01 2024
accepted: 01 02 2024
medline: 30 3 2024
pubmed: 30 3 2024
entrez: 29 3 2024
Statut: aheadofprint

Résumé

The management of head and neck cancers is multidisciplinary, often relying on the use of combined treatments to maximize the chances of cure. Combined treatments are however also responsible for cumulative side effects. The aim of reconstructive surgery with a flap is to restore a function lost with the loss of substance from the tumor resection. However, changes in reconstructive surgery have impact of postoperative radiotherapy planning. The optimization of imaging protocols for radiotherapy planning should make it possible to identify postoperative changes and to distinguish flaps from surrounding native tissues to delineate the flaps and document the spontaneous evolution of these flaps or dose-effect relationships in case of radiotherapy. Such changes include atrophy, fibrosis of soft tissue flaps and osteoradionecrosis of bone flaps. Radiotherapy optimization also involves standardization of the definition of target volumes in situations where a flap is present, a situation that is increasingly common in routine care. This evolution of practice, beyond the essential multidisciplinary consultation meetings defining treatment indications, requires a close radio surgical collaboration with respect to technical aspects of the two disciplines. Doing so, anticipation of relapse and toxicity profiles could possibly lead to propose strategies for personalized de-escalation of multimodal treatments through interdisciplinary trials.

Identifiants

pubmed: 38553286
pii: S0007-4551(24)00082-1
doi: 10.1016/j.bulcan.2024.02.002
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Alice Blache (A)

Département de radiothérapie, centre hospitalier universitaire Amiens-Picardie, 80000 Amiens, France. Electronic address: blachealice3@gmail.com.

Florent Carsuzaa (F)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Poitiers, Poitiers, France.

Arnaud Beddok (A)

Institut Jean-Godinot, Reims, France.

Sophie Deneuve (S)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Rouen, Poitiers, France.

Pierre-Yves Marcy (PY)

Polyclinics ELSAN Group, Department of Radiodiagnostics and Interventional Imaging, PolyClinics Les Fleurs, Quartier Quiez, 83189 Ollioules, France.

Dylan James (D)

Radiotherapy Department, University Hospital of Brest, Brest, France.

Catherine Dejean (C)

Radiophysics Department, Centre Lacassagne, Nice, France.

Stéphanie Dapké (S)

Departement of Maxillofacial Surgery, Research Unit, UR7516 CHIMERE, University of Picardy Jules-Verne, Institut Faire Faces, University Hospital of Amiens Picardy, Amiens Picardy, France.

Bernard Devauchelle (B)

Departement of Maxillofacial Surgery, Research Unit, UR7516 CHIMERE, University of Picardy Jules-Verne, Institut Faire Faces, University Hospital of Amiens Picardy, Amiens Picardy, France.

Juliette Thariat (J)

Department of radiotherapy, Centre François-Baclesse, Corpuscular Physics Laboratory, IN2P3, Ensicaen, CNRS UMR 6534, Université de Normandie, GORTEC, Caen, France.

Classifications MeSH